BioPorto A/S
Market rumours about rejection of NGAL cut-off patent application

BioPorto  A/S 

28.01.2015 11:11

Dissemination of a Adhoc News, transmitted by DGAP - a service of EQS Group
AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Today BioPorto became aware of market rumours that the company's divisional
cut-off patent application no. EP2128625 has been rejected by the European
Patent Office (EPO). 

These rumours are not true. As part of the normal patent application
processing, the EPO has submitted a so-called 'Office Action' to BioPorto,
requesting further clarification of a number of circumstances relating to
BioPorto's divisional NGAL cut-off patent application. 

Accordingly, the application process concerning the divisional NGAL cut-off
patent will continue according to standard EPO procedures. 





Further details from:

Peter Mørch Eriksen, CEO

Phone 45 29 00 00, mail investor@bioporto.com
News Source: NASDAQ OMX



28.01.2015 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      BioPorto  A/S
              
               
              Denmark
Phone:        
Fax:          
E-mail:       
Internet:     
ISIN:         DK0011048619
WKN:          
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------